# Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung Cancer

> **NCT04153799** · PHASE1 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 11 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cells

## Key facts

- **NCT ID:** NCT04153799
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2020-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04153799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04153799, "Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04153799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*